None listed
Conditions
Interventions
Intervention1: Quista Active: Open Label, Two Arm, Clinical Study.
40 Eligible subjects will be enrolled into two groups. Each group will have 20 subjects and will be advised to take HQAP 061801 at a
Sponsors
The Himalaya Drug Company
Eligibility
Inclusion criteria
Inclusion criteria: 1. Both male and female adult subjects between the age group of 2. More than 18 years to less than 60 years who are confirmed to have a history of work related fatigue as assessed through Fatigue assessment scale (FAS). 3. Both male and female adult subjects between the age group of More than 18 years to less than 60 years who are in post illness convalescence period. 4. Subject willing to refrain taking any other oral nutritional supplements during the study period. 5. Subjects willing to give written informed consent Subjects who had not participated in similar kind of study in last 4 week.
Exclusion criteria
Exclusion criteria: 1. Subject with clinically significant systemic illnesses treated with medication. 2. Subject with chronic illness which need immediate therapeutic intervention. 3. Subjects with chronic infectious condition treated with medications 4. Subjects who are hypersensitive to any of the ingredients, 5. Pregnant & lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall study compliance of the subject to the study medication Any adverse effects reported or observed during the study period Timepoint: The subject will be assessment visits are scheduled on day 1, day 30 days (telephonic) and at (End of Study) day 60 days. | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall study compliance of the subject to the study medication Any adverse effects reported or observed during the study period Timepoint: The whole study duration is for 30 days with scheduled follow up visits at day 1, day 14, and day 30 day. | — |
Countries
India
Contacts
Public ContactDr Palaniyamma
The Himalaya Drug Company
Outcome results
None listed